Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Type I interferons as ambiguous modulators of chronic inflammation in the central nervous system.
Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
Chronic primary central nervous system histoplasmosis in a healthy child with intermittent neurological manifestations.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
AAV1.NT-3 gene therapy for Charcot-Marie-Tooth neuropathy.
Trunk muscle activity during walking in persons with multiple sclerosis: The influence of body weight support.
Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders.
Intrinsic Functional Plasticity of the Sensorimotor Network in Relapsing-Remitting Multiple Sclerosis: Evidence from a Centrality Analysis.
Reducing falls and improving mobility in multiple sclerosis.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
Proteome analysis of spinal cord during the clinical course of monophasic experimental autoimmune encephalomyelitis.
Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
Multiple sclerosis coexisting with spinal cord ependymoma: a case report.
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Electrophysiological features of POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Apitope starts new clinical trial of its investigational Multiple Sclerosis treatment
SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β.
The control of reactive oxygen species production by SHP-1 in oligodendrocytes.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.
Assessment of jugular endovascular malformations in chronic cerebrospinal venous insufficiency: colour-Doppler scanning and catheter venography compared with intravascular ultrasound.
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »